Albany, NY -- (SBWIRE) -- 07/14/2014 -- Cocaine is a type of stimulant and appetite suppressant that can be smoked, injected and snorted. Cocaine is extracted from the leaves of the coca plant. In nature, cocaine acts as a triple reuptake inhibitor (TRI) or serotonin–norepinephrine-dopamine reuptake inhibitor, which makes it anesthetic, when taken in low doses. Globally, cocaine dependence is a major public health concern and cause of significant mortality and morbidity. Currently, cocaine dependence treatment market is a highly profitable market venture due to the large base of cocaine users and high awareness among people, which makes this industry a highly attractive and profitable market.

Browse the full report with request TOC at http://www.transparencymarketresearch.com/cocaine-dependence-treatment.html

Some of the currently available cocaine dependence medications are as follows:

Gabapentin
Vigabatrin
Baclofen
N-acetylcysteine (NAC)
Nocaine
Disulfiram
Modafinil
Propanolol

Many types of cocaine dependence treatment are available, some of which are as follows:

Withdrawal treatment and detox centers
Inpatient cocaine rehab
Intensive outpatient rehab
Addiction counseling and aftercare

North America is the leading market for cocaine dependence treatment due to the large base of cocaine users. Cocaine use is gradually growing in developing countries; however the vast bulk of the drug production is intended for the two major international markets, namely, North America and Europe. Moreover, the largest emerging market in the developing regions is seen in the Central America, Caribbean region and South America, with some estimated 3 million users. Furthermore, the estimated are far less certain for use levels of cocaine in Africa and Asia. According to the United Nations Office on Drugs and Crime (UNODC) approximately 6.2 million people in North America used cocaine in 2008 and 4 to 5 million people used cocaine in Europe including the EU and EFTA countries.

Buy This Report with 10% Discount and Customize as per Your Requirement @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2518

Cocaine use constitutes major health problems, after opiates, cocaine is the most used drug globally. Safe and effective cocaine de-addiction therapeutics has the potential to grab a profitable market share in these above-mentioned regions due to the large base of drug users and increasing awareness among the population.

Some of the major factors driving the growth of the cocaine dependence treatment market are increasing base of drug users and rising awareness among population for cocaine de-addiction therapies. It has been estimated that the number of available treatment regimens for drug abuse problems is very limited. The market is also expected to grow owing to the lack of standard treatments for either methamphetamine addiction or cocaine addiction. Moreover, a recent analysis performed by the National Institute on Drug Abuse (NIDA) estimates that the global market size for the first in class treatment for cocaine dependence is approximately USD 1.2 billion.

Thus, this potential market of cocaine dependence treatment has a remarkable scope for growth and it is recommended to the biopharmaceutical companies to invest in this dynamic field for multiplying their profit margin. Cocaine dependence vaccine is also an emerging option that can be exploited by the companies for entering into the market. However, stringent regulatory approvals and immense competition among the players already involved in this market makes it difficult for the new entrants to enter this industry.

Some of the companies involved with the development of treatment regimens for cocaine addiction are as follows Catalyst Pharmaceutical Partners, Inc., Savant HWP, Inc., Lannett Company, Inc. and Pfizer Inc.

Contact Us

Sheela AK
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/